VivoSeq
Other

Fetal Hypoxia

2

Pipeline Programs↗

0

Active Trials↗

0

Companies Involved↗

Fetal Hypoxia is an early-stage landscape with 2 programs across 0 companies. 2 programs are in Phase 3.

Intelligence

Pipeline Metrics

Competitive Density

16/100

Pipeline Velocity

0/100

Mech. Concentration

N/A

Completion Rate

N/A

Attrition Rate

0/100

Pipeline

Programs by Phase

Preclinical
No programs
Phase 1
No programs
Phase 2
No programs
Phase 32

Mannitol

B. Braun Medical Inc.

Allopurinol Sodium

UMC Utrecht

Approved
No programs

Analysis

Trial Status

1

clinical trials

Unknown status1 · 100%

Clinical Trials

Trial Activity

Antenatal Allopurinol During Fetal Hypoxia
Unknown status·UUMC Utrecht·Phase 3·NCT00189007·222 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)